Benjamin Sadacca Selected Research

TES

1/2023	Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer.
1/2023	Epigenetically controlled tumor antigens derived from splice junctions between exons and transposable elements.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benjamin Sadacca Research Topics

Disease

6	Neoplasms (Cancer) 01/2023 - 12/2015
4	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2016
2	Carcinogenesis 01/2023 - 12/2015
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Pathologic Complete Response 01/2023
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2021

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2015
2	TESIBA 01/2023 - 01/2023
2	AntigensIBA 01/2023 - 01/2023
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 01/2023
2	DNA Transposable Elements (Element, IS)IBA 01/2023 - 01/2023
2	Histones (Histone)IBA 01/2023 - 12/2015
2	Peptides (Polypeptides)IBA 01/2023 - 01/2023
2	Messenger RNA (mRNA)IBA 01/2023 - 08/2016
1	MethyltransferasesIBA 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	EpitopesIBA 01/2023
1	EWS-FLI fusion proteinIBA 01/2021
1	RNA Precursors (Precursor, mRNA)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Hormones (Hormone)IBA 01/2016
1	InterferonsIBA 01/2016
1	ChromatinIBA 12/2015

Therapy/Procedure

2	Neoadjuvant Therapy 06/2018 - 01/2016